Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin.
about
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Signaling pathway screening pl ...... cer of unknown primary origin.
@en
Signaling pathway screening pl ...... cer of unknown primary origin.
@nl
type
label
Signaling pathway screening pl ...... cer of unknown primary origin.
@en
Signaling pathway screening pl ...... cer of unknown primary origin.
@nl
prefLabel
Signaling pathway screening pl ...... cer of unknown primary origin.
@en
Signaling pathway screening pl ...... cer of unknown primary origin.
@nl
P2093
P2860
P50
P1433
P1476
Signaling pathway screening pl ...... cer of unknown primary origin.
@en
P2093
Andrew Hughes
Caroline Dive
Garry Ashton
Hui Sun Leong
John Brognard
Kathryn Simpson
Kristopher K Frese
Matthew G Krebs
Melanie Galvin
P2860
P2888
P356
10.1038/S41525-018-0055-6
P577
2018-06-20T00:00:00Z
P6179
1104468766